echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: Early atypical signs and hypometabolism of insula can predict the survival rate of patients with multiple system atrophy

    JNNP: Early atypical signs and hypometabolism of insula can predict the survival rate of patients with multiple system atrophy

    • Last Update: 2021-05-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Multiple system atrophy (MSA) is an adult-onset and sporadic neurological degenerative disease.


    Multiple system atrophy (MSA) is an adult-onset and sporadic neurological degenerative disease.


    The prognosis of MSA is poor, with a reported median survival time of 6.


    Diagnosis In this MSA patient cohort study, the goal is to find survival predictors in clinical and cerebral PET metabolic characteristics.


    Survival curve

    Early in the course of the disease (average 3 years, IQR 2-5), patients with suspected MSA diagnosed with clinical evaluation and brain PET.


    Kaplan-Meier Method to Evaluate the Survival Rate of Patients with Multiple System Atrophy Treated by OH and SSRI

    Including 85 patients.


     In short, brain PET is a meaningful prognostic assessment, especially in the diagnosis of left insular hypometabolism.


    Brain PET is a meaningful prognostic assessment, especially in the diagnosis of hypometabolism in the left insula.
    In addition, SSRIs are a potential drug candidate to slow the progression of the disease.
    GrimaldiS ,BoucekineM ,WitjasT GrimaldiS Grimaldi BoucekineM Boucekine Witjas  T Witjas , et al bmj.
    com/content/early/2021/04/22/jnnp-2020-324823" target="_blank" rel="noopener">Early atypical signs and insula hypometabolism predict survival in multiple system atrophy Journal of Neurology, Neurosurgery & Psychiatry  Published Online First:  23 April 2021.
      Published Online First : doi:  10.
    1136/jnnp-2020-324823 doi: leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.